As stated by our extensive report, providing insights on Product, Cell type, Cell Source, Technique, Application, and End-user; the Global VNA and PCAS Market accounted for 3,429.10 USD Million in 2021.

VNA & PACS, are Medical image control solutions utilized to assist diagnosis, correspond images between patients or within the identical patient at different time points to evaluate disease progression, and consider prognosis. PACS is a medical imaging technology utilized primarily in healthcare institutions to store and digitally transfer electronic images and clinically-relevant information securely.

Several factors like the existence of favorable government regulations for top markets and the increasing demand for the standard-based repository, disaster recovery, and lifecycle administration solutions are driving the growth of the market for VNAs. Consolidation of patient data by combining VNAs with electronic health records (EHR) is an important trend observed.

Due to the outbreak of COVID, the disease has spread in many nations around the globe with the WHO declaring it a public health crisis. With the unavailability of the right therapy, rise in patients, limited aids, and fear of disease amongst medical experts, the healthcare industry is toiling to deal with the pandemic situation. Doctors around the globe are studying all the information and data collected from COVID positive cases to gain more details regarding the spread and signs of this virus with the help of effective data collection and comparison.

Advancements in VNA & PACS techniques, such as perfect results and advanced software applications, are developing interest among educational institutes, research centers, hospitals, clinics, and physicians. Additionally, the excellent source of VNA & PACS will significantly increase the number of patients eligible for this procedure.

North America predicated to maintain the maximum share of the VNA and PCAS Market during the forecast period. The rising funds in the healthcare industry for enhancing healthcare infrastructure and digital health, adoption of developed imaging modalities into the healthcare sector, and government initiatives seeking to improve the utilization of EMR and telehealth services thus propelling the growth of VNA and PCAS Market in this region.

Some of the prominent players operating in the Global VNA and PCAS Market are Novarad Corporation (U.S.), Koninklijke Philips N.V. (Netherlands), INFINITT Healthcare Co., Ltd. (South Korea), Siemens Healthineers AG (Germany), Hyland Software, Inc. (U.S.), Agfa-Gevaert Group (U.S.), GE Company (U.S.), Mach7 Technologies (U.S.), FUJIFILM Holdings Corporation (Japan), BridgeHead Software Ltd. (U.K.), IBM Corporation (U.S.), Sectra AB (Sweden), ASPYRA, LLC (U.S.), and Change Healthcare Inc. (U.S.),.